2016
DOI: 10.3109/13880209.2016.1172321
|View full text |Cite
|
Sign up to set email alerts
|

In vivoantibacterial activity ofGarcinia mangostanapericarp extract against methicillin-resistantStaphylococcus aureusin a mouse superficial skin infection model

Abstract: GM-EtOH showed promising in vivo antibacterial activity against MRSA in a superficial skin infection model in mice. It is of interest to develop a topical formulation of GM-EtOH to further study its potential as a novel antibacterial agent.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

1
19
0
1

Year Published

2017
2017
2024
2024

Publication Types

Select...
8

Relationship

1
7

Authors

Journals

citations
Cited by 24 publications
(23 citation statements)
references
References 42 publications
1
19
0
1
Order By: Relevance
“…Recent reports have revealed that α-mangostin from G. mangostana fruit possesses several medicinal properties, such as anti-microbial activity against bacteria [ 4 , 12 , 13 , 14 , 15 , 16 , 17 , 18 ], anti-oxidant and neuro-protective activity [ 19 , 20 , 21 , 22 ], lipase inhibition [ 23 ], and anti-inflammatory and anti-cancer properties [ 24 ]. Biologically active molecules from medicinal plants are utilized as therapeutic agents, but most of the secondary metabolites do not exhibit optimum efficacy.…”
Section: Introductionmentioning
confidence: 99%
See 1 more Smart Citation
“…Recent reports have revealed that α-mangostin from G. mangostana fruit possesses several medicinal properties, such as anti-microbial activity against bacteria [ 4 , 12 , 13 , 14 , 15 , 16 , 17 , 18 ], anti-oxidant and neuro-protective activity [ 19 , 20 , 21 , 22 ], lipase inhibition [ 23 ], and anti-inflammatory and anti-cancer properties [ 24 ]. Biologically active molecules from medicinal plants are utilized as therapeutic agents, but most of the secondary metabolites do not exhibit optimum efficacy.…”
Section: Introductionmentioning
confidence: 99%
“…Thus, by elucidating the structure of the active compound and the pharmacophores, the functional groups are considered as essential for the bioactivity of a compound. Since α- and non-α-mangostin xanthones have been shown to possess anti-bacterial activity, especially against Gram-positive bacteria [ 12 , 13 , 14 , 15 , 16 , 17 , 18 ], it is most probable that semi-synthetic analogs would be produced with enhanced anti-bacterial activity. In order to increase the bioactivity and antibacterial properties of α-mangostin, semi-synthetic modification of the compound was performed by several authors, to lead to more active compounds [ 25 , 26 , 27 , 28 , 29 ], with no excessive toxicity.…”
Section: Introductionmentioning
confidence: 99%
“…The minimum inhibitory concentration (MIC) was evaluated by the broth dilution method in MHB as described elsewhere (9). An inoculum of MSSA or MRSA (2 × 10 6 CFU/mL) was mixed with D. alatus extracts, α,βgurjunene, dipterocarpol, oxacillin, erythromycin, and tetracycline, and incubated at 37°C for 24 hours.…”
Section: Determination Of Minimum Inhibitory Concentration and Minimumentioning
confidence: 99%
“…The transepidermal water loss (TEWL) value was measured by DermaLab ® Combo (Hadsund, Denmark) and standardized at the level of 70 -75 g/m 2 h to normalize the skin damage of all mice. After that, a 10 µL-MRSA inoculum (1 × 10 8 CFU/mL) was applied to wounds (9). A 100-µL aliquot of each sample, i.e., 10% ethanol in propylene glycol (vehicle), 20 mg/mL of D. alatus twig/oleoresin/wood extract, 4 mg/mL of α,β-gurjunene, 1.1 mg/mL of dipterocarpol, or 160 µg/mL of tetracycline, was applied to the wound area daily for nine consecutive days.…”
Section: Tape-stripping Mouse Modelmentioning
confidence: 99%
“…Currently there is a wide array of wound infection models in mice that can be used to evaluate new topical antimicrobials in vivo. These include the tape strip model (Kugelberg et al, 2005;Tatiya-aphiradee et al, 2016), incisional wound model (Lu et al, 2014), burn wound model (Liu et al, 2014;Turner et al, 2014), and a wound model that uses a biopsy punch (Zhao et al, 2010;Thompson et al, 2014;Chhibber et al, 2018). Though all have shown utility in assessing wound bacterial burden, few of the identified models lend themselves to evaluation of candidate topical antimicrobial therapies nor approximate wound healing in humans.…”
Section: Introductionmentioning
confidence: 99%